Recombinant Uncharacterized protein Mb0489c (Mb0489c)

Shipped with Ice Packs
In Stock

Product Specs

Form
Lyophilized powder.
Note: While we prioritize shipping the format currently in stock, please specify your format preference in order notes for customized fulfillment.
Lead Time
Delivery times vary depending on purchasing method and location. Consult your local distributor for precise delivery estimates.
Note: All proteins are shipped with standard blue ice packs. Dry ice shipping requires advance notice and incurs additional charges.
Notes
Avoid repeated freeze-thaw cycles. Store working aliquots at 4°C for up to one week.
Reconstitution
Centrifuge the vial briefly before opening to consolidate the contents. Reconstitute the protein in sterile deionized water to a concentration of 0.1-1.0 mg/mL. For long-term storage, we recommend adding 5-50% glycerol (final concentration) and aliquoting at -20°C/-80°C. Our standard glycerol concentration is 50%, which can be used as a reference.
Shelf Life
Shelf life depends on various factors, including storage conditions, buffer components, temperature, and protein stability. Generally, liquid formulations have a 6-month shelf life at -20°C/-80°C, while lyophilized forms have a 12-month shelf life at -20°C/-80°C.
Storage Condition
Upon receipt, store at -20°C/-80°C. Aliquoting is essential for multiple uses. Avoid repeated freeze-thaw cycles.
Tag Info
Tag type is determined during manufacturing.
The tag type is determined during production. If you require a specific tag, please inform us for preferential development.
Synonyms
BQ2027_MB0489C; Uncharacterized protein Mb0489c
Buffer Before Lyophilization
Tris/PBS-based buffer, 6% Trehalose.
Datasheet
Please contact us to get it.
Expression Region
1-348
Protein Length
full length protein
Species
Mycobacterium bovis (strain ATCC BAA-935 / AF2122/97)
Target Names
BQ2027_MB0489C
Target Protein Sequence
MTNPQGPPNDPSPWARPGDQGPLARPPASSEASTGRLRPGEPAGHIQEPVSPPTQPEQQP QTEHLAASHAHTRRSGRQAAHQAWDPTGLLAAQEEEPAAVKTKRRARRDPLTVFLVLIIV FSLVLAGLIGGELYARHVANSKVAQAVACVVKDQATASFGVAPLLLWQVATRHFTNISVE TAGNQIRDAKGMQIKLTIQNVRLKNTPNSRGTIGALDATITWSSEGIKESVQNAIPILGA FVTSSVVTHPADGTVELKGLLNNITAKPIVAGKGLELQIINFNTLGFSLPKETVQSTLNE FTSSLTKNYPLGIHADSVQVTSTGVVSRFSTRDAAIPTGIQNPCFSHI
Uniprot No.

Target Background

Subcellular Location
Cell membrane; Multi-pass membrane protein.

Q&A

What is currently known about the uncharacterized protein Mb0489c?

Mb0489c is an uncharacterized protein from Mycobacterium bovis with 348 amino acids. Its UniProt accession number is P64700, and it is encoded by the Mb0489c gene. The protein's function remains largely unknown, which is common for many proteins labeled as "uncharacterized" in genomic studies. Based on its amino acid sequence, preliminary bioinformatic analyses may suggest potential functions, but experimental validation is required to confirm these predictions .

What bioinformatic approaches should I use for initial characterization of Mb0489c?

For initial characterization, employ a multi-step bioinformatic workflow:

  • Sequence homology analysis: Use BLAST to identify similar proteins with known functions.

  • Domain prediction: Tools like Pfam, SMART, and InterPro can identify conserved domains.

  • Secondary structure prediction: Utilize JPred, PSIPRED, or PredictProtein to predict structural elements.

  • Tertiary structure modeling: Apply AlphaFold2, I-TASSER, or SWISS-MODEL for 3D structure prediction.

  • Functional annotation: GO term prediction and protein family classification.

Combine results from multiple tools to overcome limitations of individual approaches. When analyzing results, focus on confidence scores and evaluate conservation across related mycobacterial species to strengthen functional predictions .

How do I design optimal primers for cloning the Mb0489c gene?

Design primers that will facilitate efficient cloning and expression by following these methodological considerations:

  • Primer design optimization: Use the full coding sequence (1-348 amino acids) to design primers with appropriate restriction sites compatible with your expression vector.

  • Codon optimization: Consider codon usage bias in your expression host to improve protein yield.

  • Design of Experiments (DoE) approach: Rather than testing primers individually, design a factorial experiment to evaluate multiple primer pairs and conditions simultaneously.

  • Inclusion of purification tags: Incorporate sequences for affinity tags that will facilitate downstream purification.

  • Removal of problematic sequences: Check for internal restriction sites that could interfere with cloning.

Remember to include appropriate Kozak sequences for efficient translation initiation and consider adding sequences that will facilitate tag removal if needed for subsequent functional studies .

What expression systems are most appropriate for recombinant Mb0489c production?

Selection of an appropriate expression system should be based on systematic evaluation using Design of Experiments (DoE) methodology:

  • E. coli-based systems: Consider BL21(DE3), Rosetta, or SHuffle strains to address potential codon bias or disulfide bond formation issues.

  • Mycobacterial expression systems: For native folding and post-translational modifications, M. smegmatis may provide advantages due to similarities in cellular machinery.

  • Cell-free systems: For rapid screening or if the protein is toxic to host cells.

Perform a factorial design experiment testing multiple expression systems, varying induction parameters (temperature, inducer concentration, time), and analyze yields and solubility. This approach enables identification of significant factors and their interactions affecting protein expression, which cannot be achieved through one-factor-at-a-time optimization approaches .

What storage conditions maximize stability of purified Mb0489c?

Based on established protocols for recombinant Mb0489c:

  • Long-term storage: Store at -20°C or -80°C in a Tris-based buffer containing 50% glycerol that has been optimized for this protein.

  • Working aliquots: Store at 4°C for up to one week only.

  • Avoid freeze-thaw cycles: Repeated freezing and thawing is detrimental to protein stability and should be avoided.

  • Aliquot management: Prepare small aliquots during initial purification to minimize freeze-thaw cycles.

Consider performing stability studies using differential scanning fluorimetry (DSF) to identify buffer components that further enhance stability. This could include testing various pH conditions, salt concentrations, and stabilizing additives using a DoE approach to identify optimal storage formulations .

What purification strategy yields the highest purity and activity of Mb0489c?

A multi-step purification strategy is recommended:

  • Initial capture: Use affinity chromatography based on the tag determined during the production process.

  • Intermediate purification: Apply ion exchange chromatography based on Mb0489c's theoretical isoelectric point.

  • Polishing step: Size exclusion chromatography to remove aggregates and achieve final purity.

  • DoE optimization: Rather than optimizing each step individually, design a response surface methodology experiment to identify optimal conditions considering multiple factors simultaneously.

For each purification step, systematically vary parameters such as buffer composition, pH, flow rate, and column types. Measure both yield and purity after each step, and use these responses to create a mathematical model that predicts optimal conditions. This approach will be more efficient than traditional one-factor-at-a-time optimization and will account for interaction effects between parameters .

What crystallization techniques are most successful for uncharacterized mycobacterial proteins like Mb0489c?

For crystallization of uncharacterized mycobacterial proteins:

  • Initial screening: Employ sparse matrix screens specifically designed for bacterial proteins.

  • DoE for optimization: Once initial hits are identified, use response surface methodology to optimize crystallization conditions by simultaneously varying precipitant concentration, pH, temperature, and protein concentration.

  • Seeding techniques: Implement microseed matrix screening to improve crystal quality.

  • Surface entropy reduction: Consider creating mutants with reduced surface entropy if initial crystallization attempts fail.

  • Alternative approaches: If crystallization proves challenging, consider NMR spectroscopy for smaller domains or cryo-EM for larger assemblies.

Statistical analysis of crystallization outcomes will help identify the most significant factors affecting crystal formation and guide refinement of conditions. This systematic approach replaces traditional trial-and-error methods and leads to more efficient identification of optimal crystallization conditions .

How can I predict potential functional domains in Mb0489c without a solved structure?

In the absence of a solved structure, employ these complementary approaches:

  • Comparative domain analysis: Search for distant homologs with characterized domains, such as the BTB domain identified in SANBR protein, which mediates dimerization and interactions with corepressor proteins.

  • Hydrophobic cluster analysis: Identify conserved hydrophobic patterns that may indicate structural domains.

  • Limited proteolysis combined with mass spectrometry: Experimentally determine domain boundaries based on protease-resistant regions.

  • Threading approaches: Use tools that align sequences to known structures even with low sequence identity.

  • Machine learning predictions: Utilize newer AI-based tools that can predict domains based on patterns not evident in traditional sequence analysis.

Integrate results from multiple prediction methods to increase confidence in domain identification. For experimental validation, consider expressing predicted domains separately to test for folding, stability, and function .

What experimental approaches can determine the biological function of Mb0489c?

A systematic workflow for functional characterization includes:

  • Protein-protein interaction studies: Use pull-down assays, co-immunoprecipitation, or yeast two-hybrid systems to identify interaction partners.

  • Localization studies: Determine cellular localization using GFP-fusion constructs or immunofluorescence.

  • Gene knockout/knockdown: Create and phenotypically characterize M. bovis strains lacking or underexpressing Mb0489c.

  • Complementation studies: Test if Mb0489c can functionally replace proteins with similar domains in other organisms.

  • Activity screening: Design a panel of biochemical assays based on bioinformatic predictions to test for enzymatic activities.

Implement a DoE approach when testing multiple conditions in activity assays to efficiently identify optimal reaction parameters. This strategy allows for systematic exploration of potential functions with minimal experimental inputs .

How can I determine if Mb0489c forms complexes or undergoes dimerization?

To investigate complex formation and dimerization:

  • Size exclusion chromatography: Compare the elution profile of Mb0489c with known standards to determine its apparent molecular weight in solution.

  • Cross-linking studies: Use chemical cross-linkers of varying lengths followed by SDS-PAGE analysis to identify potential oligomeric states.

  • Analytical ultracentrifugation: Determine sedimentation properties to accurately measure molecular weight and oligomerization state.

  • Native mass spectrometry: Directly measure the mass of intact protein complexes.

  • FRET assays: For in vivo studies, create fluorescently labeled constructs to detect protein-protein interactions.

Analyze results within the context of related proteins. For example, if Mb0489c contains domains similar to the BTB domain found in SANBR, it might form dimers as observed with SANBR's BTB domain in both in vitro glutaraldehyde cross-linking experiments and in vivo dimerization assays .

How can I design experiments to identify transcriptional targets if Mb0489c functions as a transcriptional regulator?

If bioinformatic analysis suggests Mb0489c may function as a transcriptional regulator, implement this comprehensive workflow:

  • ChIP-seq analysis: Perform chromatin immunoprecipitation followed by sequencing to identify genomic binding sites.

  • RNA-seq comparison: Compare transcriptomes of wild-type and Mb0489c-knockout/overexpression strains to identify differentially expressed genes.

  • Electrophoretic mobility shift assays (EMSA): Validate direct binding to predicted target sequences.

  • Reporter gene assays: Construct reporter systems with predicted target promoters to quantify transcriptional effects.

  • Statistical analysis of binding motifs: Use motif discovery algorithms to identify consensus binding sequences.

Design these experiments using factorial or response surface methodology approaches to simultaneously test multiple variables, such as different growth conditions or cell types, maximizing information yield while minimizing experimental effort .

What approaches can resolve contradictory functional predictions for Mb0489c?

When facing contradictory functional predictions:

  • Domain-specific functional analysis: Express and characterize individual domains separately to dissect specific functions.

  • Evolutionary context analysis: Examine distribution and conservation patterns across species to identify evolutionary constraints.

  • Integration of multiple data types: Combine transcriptomic, proteomic, and metabolomic data to build a comprehensive functional network.

  • Bayesian statistical approaches: Apply probabilistic frameworks to weigh evidence from different experimental approaches.

  • Comparative analysis with characterized proteins: Analyze proteins with similar domain architectures, such as SANBR with its SANT and BTB domains, which has been shown to function as a negative regulator through interactions with corepressor proteins.

Design experiments that can specifically distinguish between contradictory hypotheses rather than generally exploring function. This targeted approach will more efficiently resolve functional ambiguities .

How can I apply Design of Experiments (DoE) methodology to optimize Mb0489c expression conditions?

For optimal DoE application to Mb0489c expression:

  • Factor identification: First identify key factors affecting expression, such as temperature, inducer concentration, growth media composition, and induction time.

  • Screening design selection: Begin with a fractional factorial design to screen many factors with fewer experiments.

  • Response variable definition: Clearly define what constitutes optimal expression (total yield, soluble fraction, or activity).

  • Model development: Use response surface methodology to model the relationship between factors and protein expression.

  • Optimization and validation: Use the model to predict optimal conditions, then validate experimentally.

This systematic approach is significantly more efficient than one-factor-at-a-time optimization, as it accounts for interaction effects between variables. Statistical analysis of results will identify the most significant factors affecting expression and guide refinement of conditions .

What controls and validation experiments are essential when studying an uncharacterized protein like Mb0489c?

Essential controls and validation experiments include:

  • Expression controls: Empty vector controls and expression of well-characterized proteins using the same system.

  • Activity assay controls: Positive and negative controls specific to each functional assay.

  • Antibody validation: For western blots or immunoprecipitation, verify antibody specificity using knockout strains or competing peptides.

  • Replication strategy: Design with adequate biological and technical replicates for statistical power.

  • Independent method validation: Confirm key findings using orthogonal experimental approaches.

Structure experiments to include internal validation steps, and design them to distinguish between alternative hypotheses rather than simply supporting a favored hypothesis. Statistical methods should be predetermined before experimentation to avoid bias in analysis .

Quick Inquiry

Personal Email Detected
Please use an institutional or corporate email address for inquiries. Personal email accounts ( such as Gmail, Yahoo, and Outlook) are not accepted. *
© Copyright 2025 TheBiotek. All Rights Reserved.